Prudential Financial’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
Prudential Financial's SGMT Position: Q3 2026 in Review
Prudential Financial opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 10,195 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #2418 among its holdings. This is a return to the name: Prudential Financial previously reported a position in SGMT as recently as Q1 2024.
Prudential Financial first reported a position in SGMT in Q1 2024 and has held it in 2 quarters since. The position peaked at $243K in Q1 2024. 153 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- Prudential Financial held 10,195 shares of Sagimet Biosciences worth $101K as of Q3 2026.
- Sagimet Biosciences was a new Prudential Financial position in Q3 2026.
- Sagimet Biosciences made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2418 holding.
- Prudential Financial first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 2 quarters since.
- Prudential Financial's Sagimet Biosciences position peaked at $243K in Q1 2024.
- 153 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.